Héctor Armengod
Latham & Watkins LLP
Articles
Time to Prepare for New EU Medical Device Regime
United Kingdom, European Union - May 24 2019 On 26 May 2020, Regulation (EU) 2017745 on medical devices (MDR) will become fully active, reflecting an overhaul of the current regulatory framework...
Frances Stocks Allen, Oliver Mobasser, Christoph W.G. Engeler, Henrietta J. Ditzen, Gail E. Crawford, Robbie McLaren.
MHRA Releases No-Deal Brexit Guidance for Life Sciences Companies
United Kingdom, European Union - April 4 2019 The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published a significant volume of guidance documents on various aspects of the...
Frances Stocks Allen, Oliver Mobasser, Christoph W.G. Engeler, Henrietta J. Ditzen, Gail E. Crawford, Robbie McLaren.
European Commission Proposes Framework to Screen Certain Foreign Direct Investments
European Union - September 22 2017 Proposal coordinates existing national screening mechanisms, grants the Commission powers to review investments of "Union interest." European...
Buy and Build Strategy Increases Antitrust Risk for Private Equity
Global - April 26 2017 Private equity firms have sought a greater number of buy and build opportunities in recent years, amid high valuations and competition for primary...
Post Danmark: predatory pricing in the European Union
European Union - August 20 2012 In last year’s edition, we wrote that unilateral pricing behaviour in that case, conditional discounts requires a careful approach to enforcement....
